Loading...

HIND VYOME HOLDINGS INC Capital Structure Changes 8-K Filing

VYM

HND

VYOME HOLDINGS INC

(HIND)

2025 8-K

Summary

Summary

Filing Amendment

Merger Completion

Management Changes

Merger Completion

Asset Acquisitions

Merger of Equals

Merger of Equals

Compliance Status

Equity Offerings

Equity Offerings

Equity Offerings

Forced Delisting

Merger of Equals

Asset Acquisitions

Stockholder Approvals

Director Resignation

Securities Offering

Convertible Note Issued

Equity Purchase Agreement

Earnings Report

Nasdaq Compliance Issue

Financial Results

Securities Agreement

Financial Results

Merger Agreement and Asset ...

Financial Results Announcement

Changes in Registrant's Cer...

Financial Results Announcement

Warrant Exercise Agreement

Financial Results Announcement

Securities Purchase Agreement

Exclusive License Agreement...

Earnings Reports

Financial Results Announcement

Securities Purchase Agreement

Financial Restatement

Lease Agreement

Public Offering

Amendment to Registration S...

External Links:

On May 30, 2025, ReShape Lifesciences Inc. entered into a Sales Agreement with Maxim Group LLC to sell up to $9,700,000 of its common shares in an at-the-market offering. This agreement includes a 3.0% commission on sales and $50,000 in legal fee reimbursement for Maxim.

AI Assistant

VYOME HOLDINGS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.